Intervexion Therapeutics
UEI: MS3QH9KM4EN5
• CAGE: 4GRM3
Overview
Awardee Type
Parent
Company Description
InterveXion is binding methamphetamine to release people from addiction
Name
Intervexion Therapeutics
Website
Headquarters
Little Rock, AR
United States
United States
Most Recent Award
Sept. 30, 2022
Calculating
Federal grant recipient
INTERVEXION THERAPEUTICS LLC
(UEI MS3QH9KM4EN5, CAGE 4GRM3)
is headquartered in Little Rock AR.
The organization
was founded in February 2004 and
federally registered in
July 2006.
Federal Award Analysis
Intervexion Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
INTERVEXION THERAPEUTICS LLC
UEI
MS3QH9KM4EN5
CAGE Code
4GRM3
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Other
Purpose of Registration
Federal Assistance Awards
Date Founded
Feb. 17, 2004
Initial Registration
July 20, 2006
Last Registration
Jan. 22, 2025
Registration Activation
Jan. 17, 2025
Registration Expiration
Jan. 15, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
AR
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No
People
Vendor contacts at Intervexion Therapeutics
Grant Awards
Intervexion Therapeutics direct grants
Subgrant Awards
Intervexion Therapeutics subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Intervexion Therapeutics